Evidence map›Paper›PMID 38778436›Full record

ArticleJournal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53

ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment.

Melissa L Danielson, Angelika H Claussen, Rebecca H Bitsko, Samuel M Katz, Kimberly Newsome, Stephen J Blumberg, Michael D Kogan, Reem Ghandour

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The Association of Longitudinal Atopic Dermatitis Phenotypes and Attention-Deficit/Hyperactivity Disorder in Childhood.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Improving health through research: The ABCD StudyDevelopmental cognitive neuroscience · 2026
    Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Melissa L DanielsonNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.ORCID 0000-0001-9461-0341
Angelika H ClaussenNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.
Rebecca H BitskoNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.
Samuel M KatzNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.
Kimberly NewsomeNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.
Stephen J BlumbergNational Center for Health Statistics, Centers for Disease Control and Prevention.
Michael D KoganMaternal and Child Health Bureau, Health Resources and Services Administration.
Reem GhandourMaternal and Child Health Bureau, Health Resources and Services Administration.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveTo provide updated national prevalence estimates of diagnosed attention-deficit/hyperactivity disorder (ADHD), ADHD severity, co-occurring disorders, and receipt of ADHD medication and behavioral treatment among U.S. children and adolescents by demographic and clinical subgroups using data from the 2022 National Survey of Children's Health (NSCH).

methodThis study used 2022 NSCH data to estimate the prevalence of ever diagnosed and current ADHD among U.S. children aged 3-17 years. Among children with current ADHD, ADHD severity, presence of current co-occurring disorders, and receipt of medication and behavioral treatment were estimated. Weighted estimates were calculated overall and for demographic and clinical subgroups (

resultsApproximately 1 in 9 U.S. children have ever received an ADHD diagnosis (11.4%, 7.1 million children) and 10.5% (6.5 million) had current ADHD. Among children with current ADHD, 58.1% had moderate or severe ADHD, 77.9% had at least one co-occurring disorder, approximately half of children with current ADHD (53.6%) received ADHD medication, and 44.4% had received behavioral treatment for ADHD in the past year; nearly one third (30.1%) did not receive any ADHD-specific treatment.

conclusionsPediatric ADHD remains an ongoing and expanding public health concern, as approximately 1 million more children had ever received an ADHD diagnosis in 2022 than in 2016. Estimates from the 2022 NSCH provide information on pediatric ADHD during the last full year of the COVID-19 pandemic and can be used by policymakers, government agencies, health care systems, public health practitioners, and other partners to plan for needs of children with ADHD.

Indexed as

Attention Deficit Disorder with HyperactivityComorbiditySeverity of Illness IndexAdolescentBehavior TherapyChildChild, PreschoolFemaleHealth SurveysHumansMalePrevalenceUnited States

Identifiers

PMID38778436
PMCPMC11334226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.